| Literature DB >> 28548901 |
Yoldez Houcine1, Ines Chelly1, Alia Zehani1, Linda Belhaj Kacem1, Haifa Azzouz1, Wafa Rekik1, Hend C1, Slim Haouet1, Nidhameddine Kchir1.
Abstract
Basal cell carcinoma (BCC) is the prototypical basaloid tumor of the skin. It may show various patterns simulating other cutaneous tumors due to its pleomorphism. It may have an unusal pattern of differentiation such as squamous, sebaceous, apocrine, eccrine, pilar, and endocrine differentiation. In order to establish the relative frequency of neuroendocrine differentiation in BCC, we performed a retrospective study of 33 consecutive BCCs using conventional immunohistochemistry with two neuroendocrine antibodies: Chromogranine A and synaptophysine. The age of the patients ranged from 17-83 years with mean of 65 years. The male to female ratio was 16:17. In immunohistochimestry, Chromogranine A was seen in 72.2% (24/33) while Synaptophysine was positive in 9.09% (3/33). Their expression was cytoplasmic and membranous and was seen in the periphery of these tumors in the overlying cells. Positive staining of chromogranine A was high (75-100% of tumors cells) in 9%, intermediate (25-75% of tumors cells) in 33% of cases and relatively low (<25%) in 30.3% of cases.Entities:
Keywords: basal cell carcinoma; chromogranin; neuroendocrine differentiation; synaptophysin
Mesh:
Substances:
Year: 2017 PMID: 28548901 DOI: 10.1080/15321819.2017.1331170
Source DB: PubMed Journal: J Immunoassay Immunochem ISSN: 1532-1819